Jacob Lønborg Selected Research

Jacob Lønborg Research Topics

54	ST Elevation Myocardial Infarction 04/2024 - 02/2010
31	Infarction (Infarctions) 01/2023 - 02/2010
15	Myocardial Infarction 10/2023 - 04/2012
7	Heart Failure 01/2020 - 08/2014
5	Ischemia 10/2023 - 04/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 02/2016
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 08/2014
4	Aortic Valve Stenosis (Aortic Stenosis) 01/2023 - 01/2014
3	Cicatrix (Scar) 01/2023 - 08/2012
3	Thrombosis (Thrombus) 11/2022 - 02/2013
3	Coronary Occlusion 11/2022 - 06/2012
3	Pathologic Constriction (Stenosis) 01/2022 - 02/2013
3	Reperfusion Injury 01/2021 - 06/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2018 - 01/2013
1	Non-ST Elevated Myocardial Infarction 04/2024
1	Atherosclerotic Plaque (Atheroma) 10/2023
1	Body Weight (Weight, Body) 01/2023
1	Hypokalemia 01/2020
1	Ventricular Fibrillation 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Fibrosis (Cirrhosis) 07/2017
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2017
1	Hemorrhage 05/2016
1	Stroke (Strokes) 05/2016
1	Hypertension (High Blood Pressure) 01/2015
1	Hyperglycemia 07/2014
1	Anemia 01/2014
1	Chronic Renal Insufficiency 01/2014
1	Ventricular Remodeling 07/2013

6	GadoliniumIBA 01/2023 - 08/2012
4	omega-Chloroacetophenone (Mace)IBA 10/2023 - 08/2014
4	Troponin T (Troponin T1)IBA 09/2018 - 01/2013
4	Exenatide (Byetta)FDA Link 07/2016 - 04/2012
2	danegaptideIBA 01/2023 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 07/2014 - 09/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023
1	alirocumabIBA 10/2023
1	LipidsIBA 10/2023
1	gadobutrolIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 11/2020
1	bivalirudin (Angiomax)FDA Link 04/2020
1	Heparin (Liquaemin)FDA LinkGeneric 04/2020
1	Clopidogrel (Plavix)FDA Link 01/2020
1	PotassiumIBA 01/2020
1	Prasugrel Hydrochloride FDA Link 01/2020
1	TicagrelorIBA 01/2020
1	Rubidium-82IBA 01/2019
1	TroponinIBA 09/2018
1	Liraglutide FDA Link 07/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2017
1	p38 Mitogen-Activated Protein KinasesIBA 07/2017
1	LaminsIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 07/2014
1	C-Reactive ProteinIBA 07/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	A 19IBA 02/2010

51	Percutaneous Coronary Intervention 04/2024 - 02/2010
6	Stents 11/2022 - 02/2013
4	Transcatheter Aortic Valve Replacement 01/2023 - 01/2014
3	Therapeutics 10/2023 - 11/2017
2	Thrombectomy 01/2020 - 02/2013
2	Ischemic Postconditioning 11/2017 - 01/2017
2	Ligation 07/2017 - 01/2013
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2023
1	Intravenous Injections 01/2023
1	Aftercare (After-Treatment) 01/2021
1	Resuscitation 01/2020
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020
1	Blood Transfusion (Blood Transfusions) 01/2014